Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)
This study has been completed.
First Posted: June 12, 2012
Last Update Posted: October 4, 2016
Information provided by (Responsible Party):